Mekinist .5 mg/1

Mekinist (trametinib) is a prescription medication used to treat certain types of cancer. This oral tablet is designed to target specific proteins involved in cancer cell growth.

Mekinist is primarily used in the treatment of advanced or metastatic melanoma, a type of skin cancer. It may also be used in combination with other cancer therapies to target specific genetic mutations. Patients often ask, 'What is trametinib used for?' and the answer involves its role in managing cancers with specific genetic markers.

Common effects of Mekinist may include skin-related issues such as rash or acne, as well as fatigue and diarrhea. Some patients may experience changes in blood pressure or blood sugar levels. It's important to discuss any persistent or severe effects with a healthcare provider.

Mekinist should be handled with care, stored at room temperature, and kept away from children. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring may be necessary to manage potential side effects.

Mekinist may interact with other medications, including those that affect the liver's ability to metabolize drugs. It is important to inform healthcare providers about all medications, including over-the-counter drugs and supplements, to avoid potential interactions.